Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study

BACKGROUND: Lifelong antiplatelet treatment is recommended after ischaemic vascular events, on the basis of trials done mainly in patients younger than 75 years. Upper gastrointestinal bleeding is a serious complication, but had low case fatality in trials of aspirin and is not generally thought to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linxin, Geraghty, Olivia C, Mehta, Ziyah, Rothwell, Peter M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537194/
https://www.ncbi.nlm.nih.gov/pubmed/28622955
http://dx.doi.org/10.1016/S0140-6736(17)30770-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537194/
https://www.ncbi.nlm.nih.gov/pubmed/28622955
http://dx.doi.org/10.1016/S0140-6736(17)30770-5

Ejemplares similares